Related Experiment Video
Updated: Aug 6, 2026

Vinyl Chloride and High-Fat Diet as a Model of Environment and Obesity Interaction
Published on: January 12, 2020
Class III obesity continues to rise in African-American women
Andrew Roberts1, Jennifer King, Frank Greenway
1Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
Background:
The Behavior Risk Factor Surveillance System (BRFSS) survey, a random telephone survey of the United States, found a rising prevalence of Class III obesity, body mass index (BMI) >40 kg/m(2). African-American women were largely responsible for this increase. The prevalence of Class III obesity in African-American women in the BRFSS during the year 2000 was 6%, identical to the Pennington Biomedical Research Center (PBRC) database during the same year. The PBRC Database might predict the trend in class III obesity in the years 2000-2002.
Methods:
The PBRC is an academic research center in Baton Rouge, that maintains a database with information collected by telephone regarding BMI and race, for subjects responding to solicitations to participate in clinical trials. This database contains 7787 subjects entered from 1995 through 2002, of which 1820 were African-American women and 3006 were Caucasian women. The prevalence of Class III obesity was plotted for women of these 2 racial groups and compared with the year 2000 prevalence in the BRFSS.
Results:
The prevalence of Class III obesity in African-American women increased from 0.5% in 1995 to 6% in 2000 (identical to the BRFSS) and to 7.5% in 2002. The prevalence of Class III obesity in Caucasian women remained about 3%.
Conclusion:
The prevalence of Class III obesity continues to rise in African-American women, a group with greater need and less access to obesity surgery, the only effective treatment, than Caucasian women, an inequality deserving of public policy attention.
Related Concept Videos
Obesity
Diabetes Mellitus: Type 2 and Gestational
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Type I Diabetes III: Clinical Manifestations

